MagForce AG Installs NanoActivator® at the Kiel University Hospital
MagForce AG /
MagForce AG Installs NanoActivator® at the Kiel University Hospital
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
Berlin, Germany, December 19, 2013 - MagForce AG (Frankfurt, Xetra: MF6), a
medical technology company that focuses on the field of oncology and is a leader
in the nanotechnology sector, today announced the installation of the third
NanoActivator(®). The NanoActivator(®) was installed as part of the preparations
for the new glioblastoma study at the Kiel University Hospital.
About MagForce AG'
MagForce AG is a leading medical device company in the field of nanomedicine in
oncology, listed in the entry standard (MF6). The Company's proprietary,
NanoTherm(®) therapy, enables the targeted treatment of solid tumors through the
intratumoral generation of heat via activation of superparamagnetic
nanoparticles. NanoTherm(®), NanoPlan(®), and NanoActivator(®) are components of
the therapy and have received EU-wide regulatory approval as medical devices for
the treatment of brain tumors. MagForce, NanoTherm(®), NanoPlan(®), and
NanoActivator(®) are trademarks of MagForce AG in selected countries. For more
information, please visit www.magforce.com.
Disclaimer
This release may contain forward-looking statements and information which may be
identified by formulations using terms such as "expects", "aims", "anticipates",
"intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-
looking statements are based on our current expectations and certain
assumptions, which may be subject to a variety of risks and uncertainties. The
results actually achieved by MagForce AG may substantially differ from these
forward-looking statements. MagForce AG assumes no obligation to update these
forward-looking statements or to correct them in case of developments, which
differ from those, anticipated.
For further information:
Anne Hennecke
MC Services AG
anne.hennecke@mc-services.eu
T +49 211 529252 22
FÂ +49 211 529252 29
M +49 151 12 555 759
MagForce_Press Release_December 19, 2013:
http://hugin.info/143761/R/1751288/590311.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: MagForce AG via GlobeNewswire
[HUG#1751288]